Cohen Veterans Bioscience and Parexel Biotech Collaborate on Landmark Adaptive Platform Trial Studying Posttraumatic Stress Disorder (PTSD) Pharmacotherapeutics
November 11, 2019Read moreCohen Veterans Bioscience announced its strategic collaboration with Parexel Biotech, a new division of Parexel, for CVB’s adaptive platform trial evaluating pharmacotherapeutics to treat PTSD.
Driving Progress on Veterans Brain Health
November 11, 2019Read moreCohen Veterans Bioscience would like to honor our military veterans by highlighting the ways we are transforming science to advance brain health.
The Coalition to Heal Invisible Wounds: 2019 Progress Report
November 8, 2019Read moreIn 2019, the Coalition to Heal Invisible Wounds has continued to drive an active Congressional outreach campaign aimed at making the VA a world-class partner on the most advanced research and development projects related to PTSD and TBI.
CVB Presenting Poster at American Conference on Pharmacometrics 2019
October 22, 2019Read moreOur Senior Manager of Scientific Programs Dr. Kristophe Diaz is presenting a poster on Tau at the American Conference on Pharmacometrics in Orlando, FL on October 20-23, 2019.
CVB Presenting Poster at NORD’s 2019 Rare Diseases & Orphan Products Breakthrough Summit
October 22, 2019Read moreOur Executive Director of Digital Health Dr. Daniela Brunner is presenting a poster at the National Organization for Rare Disorder’s (NORD) 2019 Rare Diseases and Orphan Products Breakthrough Summit in Washington, D.C. on October 21-22, 2019.
News
